Abstract:T cells play important roles in the pathogenesis of inflammatory bowel diseases (IBD). And ubiquitination and deubiquitination are important epigenetic modifications in immune responses. The process of how USP16 (ubiquitin carboxyl-terminal hydrolase 16) regulates the intestinal inflammation has never been explored. USP16 expression in isolated PBMCs and intestinal tissues of IBD patients and healthy controls were examined by quantitative real-time PCR (qRT-PCR) and immunohistochemistry respectively. T-cell-specific USP16 knockout mouse was generated with the Cre/LoxP technology. Colitis was induced in Rag1−/− mice by transfer of CD4+CD25-CD45RBhi T cells from C57/Bl6 or transgenic mice. T cells were isolated from mice, and the T-cell characteristics were analysed by flow cytometry and qRT-PCR. We used western blot and calcium flux to seek for the substrate of USP16, and immunoprecipitation and immunofluorescence were used to confirm the interaction. Plasmid transfection to the HEK293T cells and mass spectrometry were used to find the ubiquitinated point on the substrate. IBD patients and inflamed intestinal tissues have higher levels of USP16 than controls. T-cell-specific USP16-knockout mice exhibited less severe colitis and less CD4+ T cells infiltration than the C57/Bl6 mice. USP16-deficient T cells had homeostasis dysregulation, impaired proliferation, defected differentiation, and normal migration ability. The calcium-triggered deubiquitination of calcineurin A (CNA), encoded by Ppp3cb or Ppp3cc, in a manner consistent with these defects. We found that the CNA is constitutively ubiquitinated on lysine 327 and that the resulting polyubiquitin chain is rapidly removed by USP16 in response to intracellular calcium stimulation. The K29-linked ubiquitination of CNA impaired NFAT recruitment and the transcription of NFAT-targeted genes. Our work elucidates the physiological function of calcineurin ubiquitination and its deubiquitinase USP16 in peripheral T cells. Notably, our results provide a critical mechanism for the regulation of calcineurin activity and a novel immunosuppressive drug target for the treatment of IBD.

Usp11 Negatively Regulates Tnf Alpha-Induced Nf-Kappa B Activation by Targeting on I Kappa B Alpha

USP18 negatively regulates NF-κB signaling by targeting TAK1 and NEMO for deubiquitination through distinct mechanisms

USP7 Inhibits Osteoclastogenesis <i>via</i> Dual Effects of Attenuating TRAF6/TAK1 Axis and Stimulating STING Signaling

USP18 inhibits NF-κB and NFAT activation during Th17 differentiation by deubiquitinating the TAK1-TAB1 complex.

P037 USP16-mediated deubiquitination of calcineurin A controls peripheral T cells maintenance and attenuates intestinal inflammation

Ubiquitin-associated Domain-containing Ubiquitin Regulatory X (UBX) Protein UBXN1 is a Negative Regulator of Nuclear Factor Κb (Nf-Κb) Signaling*

Deubiquitination of NF-κB by Ubiquitin-Specific Protease-7 promotes transcription

The deubiquitinase USP7 uses a distinct ubiquitin-like domain to deubiquitinate NF-ĸB subunits

Usp16-Mediated Deubiquitination Of Calcineurin A Controls Peripheral T Cell Maintenance

HSCARG downregulates NF-κB signaling by interacting with USP7 and inhibiting NEMO ubiquitination

Ubiquitin-Specific Protease 4 (Usp4) Targets Traf2 And Traf6 For Deubiquitination And Inhibits Tnf Alpha-Induced Cancer Cell Migration

Ubiquitin-specific protease 14 regulates LPS-induced inflammation by increasing ERK1/2 phosphorylation and NF-κB activation

Ppm1a and Ppm1b Act As Ikk Beta Phosphatases to Terminate Tnf Alpha-Induced Ikk Beta-Nf-Kappa B Activation

Lys48-linked TAK1 polyubiquitination at lysine-72 downregulates TNFα-induced NF-κB activation via mediating TAK1 degradation.

USP10 Inhibits Genotoxic NF-κB Activation by MCPIP1-facilitated Deubiquitination of NEMO.

USP12 promotes CD4+ T cell responses through deubiquitinating and stabilizing BCL10

Regulation of T Cell Function by the Ubiquitin-Specific Protease USP9X Via Modulating the Carma1-Bcl10-Malt1 Complex.

Regulation of TLR-triggered Innate Immune Response by Ubiquitin-Specific Protease 25 (180.8)

USP1-regulated Reciprocal Differentiation of Th17 Cells and Treg Cells by Deubiquitinating and Stabilizing TAZ.

USP11 Is a Negative Regulator to γH2AX Ubiquitylation by RNF8/RNF168

RBCK1 Negatively Regulates Tumor Necrosis Factor- and Interleukin-1-triggered NF-κB Activation by Targeting TAB2/3 for Degradation